Concert Pharmaceuticals Presents CTP-543 Phase 1 Results at American Academy of Dermatology Annual Meeting Read more
Integral Molecular and Integrated BioTherapeutics Initiate Collaboration for Virus Vaccine Discovery Read more
Valeant Pharmaceuticals and EyeGate Enter into Licensing Agreement for EGP-437 Combination Product Read more
ICON Selected by the FDA to Validate Patient-Reported Outcome Endpoints for Antibacterial Drug Trials Read more
CTT Pharmaceutical Holdings and CanniMed Therapeutics Inc. Complete Exclusive Canadian Licensing Agreement Read more